Compare MasterCard Inc (MA) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasterCard Inc vs Koninklijke Philips NV — how do they compare? MasterCard Inc trades at $541.8 (market cap $483.71B), while Koninklijke Philips NV trades at $26.62 (market cap $26.19B). The key difference: MasterCard Inc is far larger — about 18.5× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.79%). Which is the better fit depends on your goals.
| MA | PHG | |
|---|---|---|
Market Cap | $483.71B | $26.19B |
Volume | 4,635,698 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $598.96 | $32.91 |
52-Week Low | $471.55 | $24.54 |
Enterprise Value | $494.45B | $32.46B |
Dividend Yield | 0.64% | 3.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $541.40, down 0.4% on the day, with a bullish technical outlook supported by moving averages and strong institutional buying. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $4.60 exceeding the $4.41 estimate. Revenue growth remains solid, climbing to $32.79 billion in 2025, while maintaining high net income margins above 45%. Recent news highlights Mastercard's AI initiatives in ASEAN and commitment to financial inclusion, targeting 500 million more underbanked individuals by 2030.
The investment outlook is positive, driven by consistent earnings outperformance, expanding profit margins, and a dominant market position. Risks include competitive pressures from emerging payment technologies like stablecoins and elevated valuation multiples. Analyst consensus is strongly bullish with a $634.27 price target, suggesting ~17% upside from current levels. Institutional accumulation continues, though investors should monitor execution on growth initiatives and macroeconomic impacts on consumer spending.
PHG trades at $26.80, down 0.56% with bearish technical signals. The company shows improved fundamentals with net income turning positive to $895M in 2025 after previous losses, though revenue declined slightly to $17.83B. Analyst consensus is mixed with 40.9% buy ratings but technical indicators show selling pressure. Recent developments include FDA clearances for AI-powered medical devices and strategic healthcare partnerships.
PHG presents a turnaround story with profitability recovery but faces execution risks amid competitive pressures. The stock offers value at reasonable valuations (P/E 23.67, P/S 1.29) but requires monitoring of revenue stabilization and AI product adoption. Near-term catalyst includes Q2 2026 earnings with expected EPS of $0.40.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
